BeStock  
Stocks › Biotechnology › KLRA

Kailera Therapeutics KLRA

US equityMarket cap rank #3027
$10.84 +$0.45 (+4.33%)
Pre-market · Oct 6, 4:10 am ET · After hours $11.00 +1.48%
Open$10.48
Prev close$10.39
Day range$9.85 – $11.04
Volume1.81M
Market cap$1.41B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership99.3%-0.06 pts vs. prior quarter
Institutions holding120+0 vs. prior quarter
Insider trades (recent)23 buys / 0 sellsNet buying
Short interest4.60% of floatDays to cover 7.6 · as of 15 Sep 2026
Short-sale volume share27.4%5-day average of daily volume

Short-sale volume as % of daily volume

5%20%34%49%Sep '26Sep '26Oct '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$6.75M (9 inflow days, 11 outflow days).

The five largest holders on file together own 60.5% of shares outstanding.

Largest holders

  • Bain Capital, LP20.25%
  • Bain Capital Life Sciences Investors, LLC17.42%
  • Jiangsu Hengrui Pharmaceuticals Co.,Ltd8.88%
  • RTW Investments, LP8.31%
  • Canada Pension Plan Investment Board5.63%
  • Atlas Venture Advisors, Inc.3.99%
  • FMR3.06%
  • BlackRock3.03%

By investor type

  • VC/PE Fund45.26%
  • Mutual Fund20.59%
  • Hedge Fund16.41%
  • Public Company9.38%
  • Government Pension Fund5.66%
  • Private Company1.97%
  • Individual/Insider0.03%
  • Family Office/Trust0.03%

Reported short interest has risen from 3.93% to 4.60% of float over the last 6 biweekly reports (30 Jun 2026 to 15 Sep 2026).

Short interest, by report

Report dateShares short% of floatDays to cover
15 Sep 2026 5,962,752 4.6% 7.6
31 Aug 2026 5,660,876 4.4% 6.5
14 Aug 2026 6,065,081 4.7% 20.1
31 Jul 2026 6,626,235 5.1% 13.2
15 Jul 2026 6,413,693 5.0% 9.3
30 Jun 2026 5,097,048 3.9% 3.1

Discussion

No comments yet — be the first to weigh in on KLRA.

Leave a comment

Scroll to Top